Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07460453 · ClinicalTrials.gov registry record · NA

Racial Disparities in the Expression of Paranoia

A NA study of Psychotic Disorders and Paranoia, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
480
Enrollment target
1
Study location

NCT07460453: Recruiting NA study of Psychotic Disorders and Paranoia, sponsored by Indiana University.

NCT07460453 is a NA study of Psychotic Disorders and Paranoia that is actively recruiting participants, run by Indiana University. The registered enrollment target is 480 participants, above the 234-participant average among 22 other Psychotic Disorders trials with a reported enrollment target (105% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07460453, a NA study of Psychotic Disorders and Paranoia, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
480 participants
Enrollment target
1
Study location

Study Summary

Paranoia is a pattern of thinking in which people feel suspicious or believe others may want to harm them. It can occur in many people, not only those with a mental health diagnosis, and it can affect daily life, relationships, and overall well-being. Research has consistently shown that Black Americans report higher levels of paranoia than White Americans, even when they do not have a clinical diagnosis. However, the reasons for this difference are not well understood. The goal of this study is to better understand why these differences exist. In the experimental part of the study, researchers will use a randomized design to test whether exposure to stressful experiences related to race leads to higher levels of paranoia among Black American participants. The study will also examine factors that may strengthen or weaken this effect, such as individual experiences and personal characteristics. By identifying how stressful experiences related to race influence paranoia, this research aims to improve how paranoia is measured and understood across different groups. These findings may help researchers and clinicians use more accurate and culturally appropriate tools to assess psychosis-related experiences in diverse populations.

Primary Outcome

Self-reported paranoia will be assessed immediately following the experimental task to capture acute, experimentally induced changes in paranoia. State paranoia will be measured using the Revised Green Paranoid Thought Scale (R-GPTS; Green et al., 2019), an 18-item validated Likert-type measure appropriate for clinical and nonclinical samples. Scores range from 0-72, with higher scores indicating greater state paranoia. The R-GPTS includes two subscales: (1) Ideas of Reference and (2) Ideas of P

Interventions

  • BEHAVIORAL Guided Visual Imagery Task

Study Locations (1)

Indiana

  • Department of Psychological and Brain Sciences - Bloomington

Trial Details

FieldValue
Enrollment Target 480 participants
Start Date 2026-02-13
Est. Completion 2026-06-30
Phase NA
Indiana University

890 total trials

What NCT07460453 shows while recruiting

NCT07460453 is an interventional study that assigns participants to a tested intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap, above the 234-participant average among 22 other Psychotic Disorders trials with a reported enrollment target (105% higher).

The record links to 2 conditions, with Psychotic Disorders appearing as the primary indexed condition, and to 1 intervention - of which Guided Visual Imagery Task is the first listed.

NCT07460453 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT07460453 about?

NCT07460453 is a clinical study titled "Racial Disparities in the Expression of Paranoia". Paranoia is a pattern of thinking in which people feel suspicious or believe others may want to harm them. It can occur in many people, not only those with a mental health diagnosis, and it can affect daily life, relationships, and overall well-being. Research has consistently shown that Black Ameri...

What is the current status of trial NCT07460453?

This trial is currently recruiting. It is a NA study. The enrollment target is 480 participants. The study started on 2026-02-13. Estimated completion is 2026-06-30.

What conditions does trial NCT07460453 study?

This clinical trial studies the following conditions: Psychotic Disorders, Paranoia.

What interventions are being tested in trial NCT07460453?

The interventions under investigation include: Guided Visual Imagery Task (BEHAVIORAL).

Who is sponsoring clinical trial NCT07460453?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07460453 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psychotic Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07460453's enrollment target sits among peer trials

480 2nd of 22 the highest of 22 other Psychotic Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Psychotic Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01954992 · 480 participants · Phase 3

    Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

  • NCT03023696 · 480 participants · NA

    Can Prophylactic Foraminotomy Prevent C5 Palsy

  • NCT04948060 · 480 participants · NA

    Tribally Engaged Approaches to Lung Screening (TEALS)

  • NCT05053230 · 480 participants · NA

    A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07460453, the US trial registry maintained by the National Library of Medicine. NCT07460453 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.